Dong-A Socio Holdings Co., Ltd.
Research Dong-A Socio Holdings Co., Ltd. (000640.KS) on Bullrun: market cap KRW 633.28B, dividend yield 1.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker000640.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 633.28B
- Dividend yield1.8%
- Financial periodQ2 2026
- RevenueKRW 412.39B
- Net incomeKRW 29.10B
- Free cash flowKRW 46.94B
- Gross margin34.3%
Valuation Snapshot
latest market cap is KRW 633.28B; dividend yield is 1.8%.
Peer valuation comparison
Latest dividend yield is 1.81% versus a Healthcare sector median of 2.4% (24.6% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 633.28B | n/a | 1.8% | 1700 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1700 KRW, yield 1.8%.
About Dong-A Socio Holdings Co., Ltd.
Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Dong-A Socio Holdings Co., Ltd.'s market cap?
Dong-A Socio Holdings Co., Ltd.'s market capitalization is KRW 633.28B.
Does Dong-A Socio Holdings Co., Ltd. pay a dividend?
Dong-A Socio Holdings Co., Ltd. has a dividend yield of 1.8%.
What does Dong-A Socio Holdings Co., Ltd. do?
Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments.